选择性激光小梁成形术后双方同意的眼强直反应。

Q3 Medicine
Nariman Nassiri, Frank Mei, Hassan Tokko, John Zeiter, Sarah Syeda, Chaesik Kim, Ronald Swendris, Anju Goyal, Elise In'T Veld, Alma Mas-Ramirez, Sonia W Rana, Mark S Juzych, Bret A Hughes
{"title":"选择性激光小梁成形术后双方同意的眼强直反应。","authors":"Nariman Nassiri,&nbsp;Frank Mei,&nbsp;Hassan Tokko,&nbsp;John Zeiter,&nbsp;Sarah Syeda,&nbsp;Chaesik Kim,&nbsp;Ronald Swendris,&nbsp;Anju Goyal,&nbsp;Elise In'T Veld,&nbsp;Alma Mas-Ramirez,&nbsp;Sonia W Rana,&nbsp;Mark S Juzych,&nbsp;Bret A Hughes","doi":"10.5005/jp-journals-10078-1361","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>\"Consensual ophthalmotonic reaction\" refers to changes in intraocular pressure (IOP) in one eye, which is accompanied by a corresponding change in IOP in the contralateral eye. This study evaluates whether monocular administration of selective laser trabeculoplasty (SLT) leads to a consensual ophthalmotonic reaction and how long this effect lasts.</p><p><strong>Materials and methods: </strong>A retrospective chart review was performed on patients receiving SLT at Kresge Eye Institute in Detroit, MI, from January 2015 to August 2016. Patients were excluded if they had previous history of glaucoma incisional and/or laser procedures; required additional laser trabeculoplasty; had glaucoma medication changes during the follow-up period; experienced no decrease in IOP during the follow-up period; or had a diagnosis of angle closure on gonioscopy. Various demographic, clinical, and surgical data were collected. IOP measurements were collected at baseline and postoperatively at 1-3 months, 4-9 months, and 12-15 months.</p><p><strong>Results: </strong>At all follow-up periods, the IOP of the treated eye was decreased from baseline IOP (<i>p</i> ≤ 0.05, paired <i>t</i>-test). For the fellow eye, there was a statistically significantly decrease from baseline up to the 4-9 months follow-up period (<i>p</i> ≤ 0.05, paired <i>t</i>-test). Linear regression analysis of the percent reduction in IOP from baseline in the SLT-treated eye with the fellow eye shows a mild correlation at all-time points: R<sup>2</sup> = 0.284 (<i>p</i> < 0.001) at 1-3 months; R<sup>2</sup> = 0.348 (<i>p</i> < 0.001) at 4-9 months; R<sup>2</sup> = 0.118 (<i>p</i> = 0.054) at 12-15 months.</p><p><strong>Conclusion: </strong>This study showed that monocular administration of SLT results in a consensual ophthalmotonic reaction. The consensual ophthalmotonic reaction appears to last for up to 4-9 months.</p><p><strong>Clinical significance: </strong>Therefore, although SLT does lead to a consensual ophthalmotonic reaction, monocular administration of SLT is not a reliable method of long-term IOP control for the contralateral non-SLT-treated eye.</p><p><strong>How to cite this article: </strong>Nassiri N, Mei F, Tokko H, <i>et al.</i> Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty. J Curr Glaucoma Pract 2022;16(1):36-40.</p>","PeriodicalId":15419,"journal":{"name":"Journal of Current Glaucoma Practice","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/10/7c/jocgp-16-36.PMC9385382.pdf","citationCount":"0","resultStr":"{\"title\":\"Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty.\",\"authors\":\"Nariman Nassiri,&nbsp;Frank Mei,&nbsp;Hassan Tokko,&nbsp;John Zeiter,&nbsp;Sarah Syeda,&nbsp;Chaesik Kim,&nbsp;Ronald Swendris,&nbsp;Anju Goyal,&nbsp;Elise In'T Veld,&nbsp;Alma Mas-Ramirez,&nbsp;Sonia W Rana,&nbsp;Mark S Juzych,&nbsp;Bret A Hughes\",\"doi\":\"10.5005/jp-journals-10078-1361\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim: </strong>\\\"Consensual ophthalmotonic reaction\\\" refers to changes in intraocular pressure (IOP) in one eye, which is accompanied by a corresponding change in IOP in the contralateral eye. This study evaluates whether monocular administration of selective laser trabeculoplasty (SLT) leads to a consensual ophthalmotonic reaction and how long this effect lasts.</p><p><strong>Materials and methods: </strong>A retrospective chart review was performed on patients receiving SLT at Kresge Eye Institute in Detroit, MI, from January 2015 to August 2016. Patients were excluded if they had previous history of glaucoma incisional and/or laser procedures; required additional laser trabeculoplasty; had glaucoma medication changes during the follow-up period; experienced no decrease in IOP during the follow-up period; or had a diagnosis of angle closure on gonioscopy. Various demographic, clinical, and surgical data were collected. IOP measurements were collected at baseline and postoperatively at 1-3 months, 4-9 months, and 12-15 months.</p><p><strong>Results: </strong>At all follow-up periods, the IOP of the treated eye was decreased from baseline IOP (<i>p</i> ≤ 0.05, paired <i>t</i>-test). For the fellow eye, there was a statistically significantly decrease from baseline up to the 4-9 months follow-up period (<i>p</i> ≤ 0.05, paired <i>t</i>-test). Linear regression analysis of the percent reduction in IOP from baseline in the SLT-treated eye with the fellow eye shows a mild correlation at all-time points: R<sup>2</sup> = 0.284 (<i>p</i> < 0.001) at 1-3 months; R<sup>2</sup> = 0.348 (<i>p</i> < 0.001) at 4-9 months; R<sup>2</sup> = 0.118 (<i>p</i> = 0.054) at 12-15 months.</p><p><strong>Conclusion: </strong>This study showed that monocular administration of SLT results in a consensual ophthalmotonic reaction. The consensual ophthalmotonic reaction appears to last for up to 4-9 months.</p><p><strong>Clinical significance: </strong>Therefore, although SLT does lead to a consensual ophthalmotonic reaction, monocular administration of SLT is not a reliable method of long-term IOP control for the contralateral non-SLT-treated eye.</p><p><strong>How to cite this article: </strong>Nassiri N, Mei F, Tokko H, <i>et al.</i> Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty. J Curr Glaucoma Pract 2022;16(1):36-40.</p>\",\"PeriodicalId\":15419,\"journal\":{\"name\":\"Journal of Current Glaucoma Practice\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/10/7c/jocgp-16-36.PMC9385382.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Current Glaucoma Practice\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5005/jp-journals-10078-1361\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Current Glaucoma Practice","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10078-1361","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

目的:“两感性眼强直反应”是指单眼眼内压(IOP)的变化,同时伴有对侧眼IOP的相应变化。本研究评估单眼选择性激光小梁成形术(SLT)是否会导致双方同意的眼强直反应,以及这种效果持续多久。材料和方法:对2015年1月至2016年8月在密歇根州底特律市Kresge眼科研究所接受SLT治疗的患者进行回顾性图表回顾。排除既往有青光眼切口和/或激光手术史的患者;需要额外的激光小梁成形术;随访期间有青光眼药物变化;随访期间眼压未下降;或经阴道镜诊断为闭角。收集了各种人口统计、临床和手术数据。在基线和术后1-3个月、4-9个月和12-15个月时收集IOP测量值。结果:在所有随访期间,治疗眼的IOP较基线IOP下降(p≤0.05,配对t检验)。对于同侧眼,从基线到随访4-9个月,有统计学意义显著下降(p≤0.05,配对t检验)。线性回归分析显示,slt治疗的眼与其他眼的IOP从基线下降的百分比在所有时间点上都有轻微的相关性:在1-3个月时,R2 = 0.284 (p < 0.001);4-9个月时R2 = 0.348 (p < 0.001);12-15个月时R2 = 0.118 (p = 0.054)。结论:本研究显示单眼注射SLT可引起自愿的眼强直反应。双方同意的眼强直反应似乎持续长达4-9个月。临床意义:因此,尽管SLT确实会导致双方同意的眼强直反应,但对于未接受SLT治疗的对侧眼睛,单眼给药SLT并不是长期控制IOP的可靠方法。文章引用方式:Nassiri N, Mei F, Tokko H,等。选择性激光小梁成形术后双方同意的眼强直反应。中华实用青光眼杂志;2009;16(1):1 -4。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty.

Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty.

Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty.

Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty.

Aim: "Consensual ophthalmotonic reaction" refers to changes in intraocular pressure (IOP) in one eye, which is accompanied by a corresponding change in IOP in the contralateral eye. This study evaluates whether monocular administration of selective laser trabeculoplasty (SLT) leads to a consensual ophthalmotonic reaction and how long this effect lasts.

Materials and methods: A retrospective chart review was performed on patients receiving SLT at Kresge Eye Institute in Detroit, MI, from January 2015 to August 2016. Patients were excluded if they had previous history of glaucoma incisional and/or laser procedures; required additional laser trabeculoplasty; had glaucoma medication changes during the follow-up period; experienced no decrease in IOP during the follow-up period; or had a diagnosis of angle closure on gonioscopy. Various demographic, clinical, and surgical data were collected. IOP measurements were collected at baseline and postoperatively at 1-3 months, 4-9 months, and 12-15 months.

Results: At all follow-up periods, the IOP of the treated eye was decreased from baseline IOP (p ≤ 0.05, paired t-test). For the fellow eye, there was a statistically significantly decrease from baseline up to the 4-9 months follow-up period (p ≤ 0.05, paired t-test). Linear regression analysis of the percent reduction in IOP from baseline in the SLT-treated eye with the fellow eye shows a mild correlation at all-time points: R2 = 0.284 (p < 0.001) at 1-3 months; R2 = 0.348 (p < 0.001) at 4-9 months; R2 = 0.118 (p = 0.054) at 12-15 months.

Conclusion: This study showed that monocular administration of SLT results in a consensual ophthalmotonic reaction. The consensual ophthalmotonic reaction appears to last for up to 4-9 months.

Clinical significance: Therefore, although SLT does lead to a consensual ophthalmotonic reaction, monocular administration of SLT is not a reliable method of long-term IOP control for the contralateral non-SLT-treated eye.

How to cite this article: Nassiri N, Mei F, Tokko H, et al. Consensual Ophthalmotonic Reaction Following Selective Laser Trabeculoplasty. J Curr Glaucoma Pract 2022;16(1):36-40.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Current Glaucoma Practice
Journal of Current Glaucoma Practice Medicine-Ophthalmology
CiteScore
1.00
自引率
0.00%
发文量
38
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信